Start for free
Start for free
Cambrian Biopharma logo

Cambrian Biopharma

North America, New York, United States, New York

Description

Cambrian is a distributed development company building therapeutics to lengthen health span.

Investor Profile

Cambrian Biopharma has made 8 investments, with 0 in the past 12 months and 63% as lead.

Stage Focus

  • Series A (38%)
  • Seed (25%)
  • Series B (25%)
  • Series C (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
  • Therapeutics
  • Biopharma
  • Health Care
  • Pharmaceutical
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cambrian Biopharma frequently co-invest with?

CaaS Capital Management
CaaS Capital Management
North America, New York, United States, New York
Co-Investments: 1
Future Ventures
Future Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
LG Technology Ventures
LG Technology Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
Clough Capital Partners
Clough Capital Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
CAM Capital
CAM Capital
North America, New York, United States, New York
Co-Investments: 1
Asymmetry Ventures
Asymmetry Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Presight Capital
Presight Capital
North America, California, United States, West Hollywood
Co-Investments: 2
Apeiron Investment Group
Apeiron Investment Group
Europe, NA - Malta, Malta, Sliema
Co-Investments: 2

Which angels does Cambrian Biopharma often collaborate with?

BB
Bruce Barclay
North America, California, United States
Shared Deals: 1
KW
Kent Wakeford
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Cambrian Biopharma?

Amplifier Therapeutics

New York, New York, United States

Amplifier Therapeutics is a biopharmaceutical firm, developing AMP-activated protein kinase (AMPK) activator molecules.

BiopharmaBiotechnologyLife Science
Series AOct 17, 2023
Amount Raised: $33,250,000
Vita Therapeutics

Baltimore, Maryland, United States

Vita Therapeutics is a cell engineering company that develops life-transformative treatments.

BiotechnologyMedicalTherapeutics
Series BOct 12, 2022
Amount Raised: $31,000,000
Oviva Therapeutics

New York, New York, United States

Oviva Therapeutics is a movement to improve women's experience of aging through biomedical research, development and advocacy.

BiotechnologyHealth Care
SeedMay 19, 2022
Amount Raised: $11,500,000
Vita Therapeutics

Baltimore, Maryland, United States

Vita Therapeutics is a cell engineering company that develops life-transformative treatments.

BiotechnologyMedicalTherapeutics
Series AJun 23, 2021
Amount Raised: $32,000,000
Arcellx

Gaithersburg, Maryland, United States

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Series CApr 13, 2021
Amount Raised: $115,000,000
Sensei Biotherapeutics

Gaithersburg, Maryland, United States

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.

BiotechnologyHealth DiagnosticsLife ScienceMedicalTherapeutics
Series BJan 11, 2021
Amount Raised: $30,000,000
Sensei Biotherapeutics

Gaithersburg, Maryland, United States

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.

BiotechnologyHealth DiagnosticsLife ScienceMedicalTherapeutics
Series AOct 7, 2020
Amount Raised: $28,500,000
Samsara Therapeutics

Boston, Massachusetts, United States

Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.

BiopharmaBiotechnologyLife SciencePharmaceutical
SeedDec 20, 2019
Amount Raised: $3,200,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator